MariMed Inc (MRMD)
0.2585
0.00 (0.00%)
USD |
OTCM |
Apr 24, 15:59
MariMed Debt to Equity Ratio: 0.9275 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.9275 |
| September 30, 2023 | 0.625 |
| June 30, 2023 | 0.6393 |
| March 31, 2023 | 0.8003 |
| December 31, 2022 | 0.5052 |
| September 30, 2022 | 0.4849 |
| June 30, 2022 | 0.4777 |
| March 31, 2022 | 0.4004 |
| December 31, 2021 | 0.4932 |
| September 30, 2021 | 0.5241 |
| June 30, 2021 | 0.7047 |
| March 31, 2021 | 1.260 |
| December 31, 2020 | 4.230 |
| September 30, 2020 | 58.44 |
| June 30, 2020 | -10.61 |
| March 31, 2020 | -5.210 |
| December 31, 2019 | 5.273 |
| September 30, 2019 | 0.4191 |
| June 30, 2019 | 0.4273 |
| March 31, 2019 | 0.3294 |
| December 31, 2018 | 0.2415 |
| September 30, 2018 | 0.3327 |
| June 30, 2018 | 0.7541 |
| March 31, 2018 | 1.455 |
| Date | Value |
|---|---|
| December 31, 2017 | 1.506 |
| September 30, 2017 | 1.069 |
| June 30, 2017 | 1.449 |
| March 31, 2017 | 34.97 |
| December 31, 2016 | -5.720 |
| September 30, 2016 | -3.531 |
| June 30, 2016 | -2.482 |
| March 31, 2016 | -2.594 |
| December 31, 2015 | -1.636 |
| September 30, 2015 | -2.584 |
| June 30, 2015 | -1.983 |
| March 31, 2015 | -1.340 |
| December 31, 2014 | -1.216 |
| September 30, 2014 | 1.092 |
| June 30, 2014 | -0.3737 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-10.61
Minimum
Jun 2020
58.44
Maximum
Sep 2020
3.201
Average
0.5241
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions Inc | 1.325 |
| Zymeworks Inc | 0.00 |
| Viemed Healthcare Inc | 0.0621 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 196.12M |
| Total Liabilities (Quarterly) | 126.21M |
| Shareholders Equity (Quarterly) | 71.56M |
| Current Ratio | 1.666 |
| Net Debt Paydown Yield | -7.86% |